Podcasts about Ophthalmology

With ophthalmology being the busiest NHS outpatient specialty, with around 9.7 million appointments in England in 2024, the Royal College of Ophthalmology's new president, Mohamed Elalfy undoubtedly has a busy three years in the role ahead. Mohamed speaks with In Touch about his plans for the College and about issues of concern to eye health and care patients, including the issue of long waiting times for appointments and potential new treatments for eye diseases.Caroline Mackenzie contacted In Touch with concerns over whether or not her young grandson should learn braille. She has been wondering whether or not it will be worth his time, given how quickly assistive technology is evolving. Does braille have a future in the face of evolving technologies? To share your thoughts on this, please email intouch@bbc.co.uk or leave a voice message on 0161 836 1338.Presenter: Peter White Producer: Beth Hemmings Production Coordinator: Helen Surtees Website image description: Peter White sits smiling in the centre of the image, wearing a dark green jumper. Above Peter's head is the BBC logo (three individual white squares house each of the three letters). Bottom centre and overlaying the image are the words "In Touch"; and the Radio 4 logo (the word Radio in a bold white font, with the number 4 inside a white circle). The background is a bright mid-blue with two rectangles angled diagonally to the right. Both are behind Peter, one of a darker blue and the other is a lighter blue.

Engineering a solution is one thing; making it work in a high-stakes clinical environment is another. This panel discussion features the minds who build the tech and the hands that use it. Leading bioengineers and frontline clinicians from NYU, NYU Abu Dhabi, the University of Michigan and the University of Maine deconstruct the challenges of medical device innovation. The topics include glaucoma and other chronic diseases such as metabolic, cardiovascular, and neurologic diseases. The discussion also touches on AI, robotics, and wearable technology to improve patient care. Panel Members Andreas Hielscher, Professor of of Biomedical Engineering, NYU Tandon School of Engineering Shy Shoham, Professor of Neuroscience and Ophthalmology, NYU School of Medicine and Tech4Health Giovanna Guidoboni, Professor of Electrical and Computer Engineering and Dean of Engineering and Computing, University of Maine Manjool Shah, Clinical Associate Professor of Ophthalmology and Visual Sciences and Associate Chair of Innovation, University of Michigan Sefy Paulose Joshi, Assistant Professor of Ophthalmology, NYU Langone Health Moderated by Yong-Ak (Rafael) Song, Professor of Mechanical Engineering and Bioengineering and 19 Washington Square North Faculty Fellow, NYUAD

In our latest episode we discuss the results of a novel approach to the treatment of geographic atrophy using Xelafaslatide a Fas inhibitor with Dr. David Zacks, Professor of Ophthalmology at the Kellogg Eye Center at the University of Michigan.

Transforming healthcare delivery in resource-limited contexts around the world calls for compassionate, innovative solutions. Learn how The Luke Commission is bringing healthcare to the most isolated and underserved in Eswatini through a scalable model for advancing health equity.

In our latest episode, we discuss the use of inhibitors of IL-6 in the treatment of retinal disease with Dr. Steven M. Yeh, Stanley M. Truhlsen, Jr. , Chair of Ophthalmology a the University of Nebraska.

OKYO Pharma's CEO Robert Dempsey joined Steve Darling from Proactive to announce the appointment of Dr. Marta Sacchetti, MD, PhD, as the newest member of the company's Scientific Advisory Board (SAB), a move designed to further strengthen the company's scientific and clinical expertise as it advances its lead ophthalmic programs. Dempsey explained that Sacchetti's addition enhances OKYO Pharma's already distinguished global network of scientific and medical advisors. Widely recognized for her expertise in neuro-inflammatory corneal diseases, Sacchetti brings deep knowledge and extensive research experience that aligns with the company's mission to address significant unmet needs in ophthalmology and ocular surface disease treatment. Sacchetti currently serves as an Associate Professor of Ophthalmology at Link University in Rome, Italy, and has built a strong reputation through her work spanning clinical practice, research, and industry collaboration. Her previous experience as Global Head of Clinical Development, Ophthalmology & Neurotrophins at Dompé Farmaceutici adds another important dimension to her expertise, particularly in areas involving targeted nerve regeneration, pain signaling modulation, and advanced diagnostic approaches. Her research efforts have focused heavily on degenerative, allergic, and neuroimmune diseases affecting the cornea and ocular surface. In addition to her clinical contributions, Sacchetti has authored numerous peer-reviewed scientific publications and presented her findings at leading national and international conferences, reinforcing her standing within the global ophthalmology community. Dempsey noted that her appointment comes at an important stage for OKYO Pharma as the company advances its investigational treatment pipeline. The company's lead product candidate, Urcosimod, continues to gain attention as the first investigational therapy to receive an Investigational New Drug (IND) designation specifically for the treatment of neuropathic corneal pain. The program has also been granted Fast Track designation by the U.S. Food and Drug Administration, potentially accelerating its path through development and regulatory review. The appointment reflects OKYO Pharma's ongoing strategy of adding specialized expertise to support the development and commercialization of novel therapies aimed at addressing challenging ophthalmic conditions. #proactiveinvestors #okyopharmalimited #nasdaq #okyo #Urcosimod #NeuropathicCornealPain #HealthcareInnovation #ClinicalDevelopment #NeuroInflammation #CornealDisease #Pharmaceuticals #MedTech #DrugDevelopment #MartaSacchetti

It's our first episode dedicated to paediatric ophthalmology - and we're joined by one of the world's leading experts - Professor Ramesh Kekunnaya, Head of Paediatric Ophthalmology, Strabismus and Neuro-ophthalmology at the LV Prasad Eye Institute in Hyderabad, author of more than 250 publications, and one of the founding members of the World Society of Paediatric Ophthalmology and Strabismus.This episode is packed with practical insights and the hottest topics shaping paediatric eye care today. We dive into:• How Ramesh decides whether - and when - to implant an IOL in a child's eye• The big question in infant cataract surgery: is it actually safer to wait longer?• What the WSPOS Myopia Consensus means for clinicians and parents navigating treatment options• How telemedicine and AI are transforming the screening and treatment of ROPAnd we also go back to fundamentals - with Ramesh sharing his top tips for examining infants and young children, plus an inside look at how the LV Prasad network delivers eye care to an astonishing 30 million people.And for subscribers, the Bonus episode goes even deeper:• Emerging myopia treatments - from blue-light therapy delivered with virtual reality headsets to competing defocus technologies.• A customised approach to treatment: where to start, what to combine, and when to escalate• The role of peripheral refraction - and how to actually measure it• Red flags for syndromic and retinal dystrophy-related myopiaTo access all Bonus episodes and our monthly newsletters, head to Eyes on Tomorrow on SubstackSpecial thanks to Topcon Healthcare and Théa UK for supporting the podcast - and to Matt Hill and the Rethink Audio team for bringing it all together. This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit eyesontomorrow.substack.com/subscribe

This is the first episode on our special mini-series on sleep. Professor Russell Foster is Professor of Circadian Neuroscience, Director of the Nuffield Laboratory of Ophthalmology and the Head of the Sleep and Circadian Neuroscience Institute at the University of Oxford. He is the author of the Sunday Times bestseller 'Life Time'.In this episode, we take a whirlwind tour of how we've developed circadian rhythms and how they orchestrate pretty much every function in our body. We turn the focus onto sleep, of course, and speak about the impact of shift work, what is known about the sleep disruption in mental illness (chicken or egg?!) and much more. You can see more of Prof Foster's research at https://www.scni.ox.ac.uk/Interviewed by Dr. Anya Borissova with Dr. Rosy Blunstone. Dr. Borissova is an academic psychiatry registrar at the South London and Maudsley Trust. Dr. Blunstone is a psychiatry and psychotherapy registrar in London. Check out The Thinking Mind  on Substack: https://substack.com/@thinkingmindpodcastIf you would like to invite Alex to speak at your organisation please email alexcurmitherapy@gmail.com with "Speaking Enquiry" in the subject line.Alex is not currently taking on new psychotherapy clients, if you are interested in working with Alex for focused behaviour change coaching , you can email - alexcurmitherapy@gmail.com with "Coaching" in the subject line. Give feedback here - thinkingmindpodcast@gmail.com Follow us here: Twitter @thinkingmindpod Instagram @thinkingmindpodcast

What is cultural distress? It is a negative response rooted in a cultural conflict where the patient lacks control over their situation. It results in more physiologic effects on the body resulting in allostatic overload. To prevent this, healthcare practitioners must use strategies such as cultural humility to help patients navigate healthcare. Come find the best ways to deliver culturally sensitive care in any setting.

In this episode, we discuss the use of aflibercept 8mg for the management of retinal vein occlusion and the results of the QUASAR study with Dr. Sunir Garg, Co Director of Retina Research at the Wills Eye Hospital and Professor of Ophthalmology at Thomas Jefferson University.

In this episode of Reboot IT, host Dave Coriale, president of DelCor, sits down with Joe Carr, Vice President of Information Technology at the American Academy of Ophthalmology, who shares how “light governance” can encourage experimentation while still protecting member data and intellectual property. They also discuss IT's evolving role as an enabler rather than a gatekeeper, the importance of data hygiene and content management, and why fostering an entrepreneurial mindset matters more than chasing the perfect AI policy. The conversation offers guidance for IT leaders and non-technical staff alike on how to safely and usefully integrate AI into daily work.Themes and Topics:Light AI Governance vs. OverengineeringKeeping AI governance policies short (3–5 pages) and written in plain language.Establishing “rules of the road” instead of rigid, draconian controls.Allowing experimentation while increasing oversight for sensitive data use.IT's Evolving Role: From Gatekeeper to EnablerIT provides secure platforms, guardrails, and integration—not every AI solution.Encouraging staff to explore AI independently within safe environments.“Making the sandbox” so staff can build their own solutions.Multiple AI Tools, One StrategySupporting several leading platforms (Copilot, Claude, OpenAI, Gemini) based on use cases.Focusing on how tools are used, not controlling which tool is used.Ensuring security, legal review, and IP protection across platforms.Data Hygiene and Content Management as AI FoundationsRecognizing that outdated or unmanaged content can undermine AI results.Shifting from document retention to true knowledge management.Designing content and websites so AI can surface accurate, relevant information.Encouraging AI Curiosity Through CultureUsing non-IT staff to demonstrate real-world AI use cases.Hosting lunch-and-learns, showcases, and Teams channels for sharing ideas.Executive support as a key driver of experimentation and adoption.Entrepreneurial Thinking and Mission AlignmentEmbracing experimentation and being willing to fail safely.Using AI to rethink workflows, not just automate existing tasks.Tying AI initiatives back to organizational mission and business goals.

Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. The industry is buzzing with significant shifts driven by scientific advancements, strategic acquisitions, and regulatory changes. A noteworthy transaction is Bayer's $2.4 billion acquisition of Perfuse, aimed at gaining control over an eye disease implant that has shown promising results in phase 2 trials. This acquisition speaks to Bayer's commitment to expanding its ophthalmology portfolio, a field with substantial unmet medical needs due to aging populations. The move highlights how companies are investing heavily in areas expected to see growing patient demand. In the realm of artificial intelligence, Recursion Pharmaceuticals is undergoing a strategic transformation under new leadership. After a decade of AI-driven research without yielding tangible products, the focus is shifting towards translating AI's potential into viable therapeutic solutions. This reflects a broader industry trend where the promise of AI must be balanced with pragmatic strategies to ensure commercial success. Novo Nordisk is making strides with its GLP-1/amylin combo treatment Cagrisema, maintaining its launch plans despite technical setbacks with a single-chamber device design. This demonstrates the company's adaptability in overcoming hurdles to bring innovative diabetes treatments to market, crucial in the competitive landscape of diabetes care. Additionally, Novo Nordisk's obesity treatment Wegovy has posted impressive quarterly revenues of $355 million thanks to strategic pricing and timely market entry ahead of competitors like Eli Lilly in the emerging oral obesity therapy segment. Such success suggests potential redefinition of market dynamics in obesity treatments. GlaxoSmithKline has entered into a $1 billion agreement with China's Siranbio for an oligonucleotide therapy targeting abdominal fat reduction. This partnership highlights GSK's strategic focus on cardiometabolic diseases through nucleic acid-based therapies, which offer high specificity and efficacy. Such therapeutics are becoming increasingly attractive for investment due to their potential impact on diverse health conditions. CellCentric's successful Series D funding round, raising $220 million for its myeloma drug, positions it well for pursuing clinical milestones independently. This signifies a shift towards self-reliant biotech models, illustrating how smaller companies are increasingly able to navigate the drug development landscape without traditional pharma partnerships. Gilead's acquisition of Arcellx for $7.8 billion and its subsequent workforce consolidation reflect ongoing realignments within the CAR-T therapy space. These consolidations indicate strategic prioritization within large biopharmaceutical companies to streamline operations while focusing on promising therapeutic areas like CAR-T cells. In corporate restructuring news, Gilead Sciences announced workforce reductions following its acquisition of Arcellx. While aimed at optimizing operations post-acquisition, it raises concerns about job security amid increasing merger activities within the biotech sector. Avalo's promising phase 2 results in skin disease treatment have renewed interest despite challenges from placebo comparisons. This emphasizes the competitive dynamics and high stakes in dermatological drug development, where even modest efficacy signals can significantly drive market activity. BioCryst's decision to halt its diabetic macular edema program to concentrate on rare diseases exemplifies a strategic pivot towards niche markets with potentially higher returns and less competition. This aligns with broader industry trends emphasizing precision medicine and targeted therapies. Eli Lilly's substantial $4.5 billion investment into its Indiana manufacturing complex underscores a commiSupport the show

In this episode, we talk with ophthalmologist Dr. Jennifer Grin about a practical, high-yield approach to evaluating eye complaints, documenting findings, and knowing when to urgently refer. The conversation covers a breakdown of an “easy eye exam” any clinician can do from starting with visual acuity as the eye's vital sign to realistic expectations for the fundus exam. Dr. Grin reviews warning signs such as sudden vision loss, abnormal pupils, flashes/floaters with a curtain (retinal detachment), and concerning trauma. She also highlights common pitfalls like mislabeling serious diseases like conjunctivitis, missing open globe injuries, and prescribing topical steroids or anesthetics without a clear diagnosis. Feedback or episode ideas email the show at wnlpodcast@copic.comDisclaimer: Information provided in this podcast should not be relied upon for personal, medical, legal, or financial decisions and you should consult an appropriate professional for specific advice that pertains to your situation. Health care providers should exercise their professional judgment in connection with the provision of healthcare services. The information contained in this podcast is not intended to be, nor is it, a substitute for medical diagnosis, treatment, advice, or judgment relative to a patient's specific condition.

Blake Williamson, MD, MPH, and Gary Wörtz, MD, return for a new season of Ophthalmology off the Grid! This season, the hosts dive into the basics of training and education at the most prestigious programs in ophthalmology across the United States. In this episode, they invite Pavlina Kemp, MD, residency program director at the University of Iowa Department of Ophthalmology and Visual Sciences, and Samuel Tadros, MD, a PGY-4 ophthalmology resident, to share a state of the union on ophthalmology residency. They discuss what it takes to stand out during the application and interviewing process and find success in the field.

How accurate is ChatGPT responding to patient questions at a 6th grade reading level vs. a 12th grade reading level? Find out in this episode as Drs. Rukhsana Mirza and Angelo Tanna discuss their Ophthalmology Science article, "Accuracy and Readability of Chat Generative Pre-Trained Transformer-4 Omni in Answering Ophthalmology Patient Questions." Accuracy and Readability of Chat Generative Pre-Trained Transformer-4 Omni in Answering Ophthalmology Patient Questions. Hamzeh, Nikoo et al. Ophthalmology Science, Volume 6, Issue 2. Looking for ways to give back? By becoming an EyeCare America volunteer, you could help provide eye care to those in your community most in need, from the comfort of your own office. EyeCare America, established by the American Academy of Ophthalmology in 1985 as the first public service program for eye care, connects uninsured and underinsured patients 18 and over in need of medical eye exams with local ophthalmologists. Visit eyecareamerica.org for more info.

Hey, Doc! What's Wrong with My Eye?: A General Guide to Eye Symptoms by John C Barber, MD, FAAOThis book is a primer on eye disease. It is written for the nonphysician but would benefit physicians and paramedical personnel who are not eye physicians. Dr. Barber explains the common signs and symptoms of eye diseases and explains the usual treatments for these diseases, including glaucoma, cataracts, macular degeneration, and strabismus. It contains chapters about the ways diabetes, thyroid disease, AIDS, and other systemic diseases affect the eye. Several chapters explain the surgery for correction of cataracts, retinal detachment, crooked eyes, and glaucoma. There is a section on eye diseases of childhood. This book is recommended for employees in ophthalmic offices to better understand patient problems and the doctor's treatments.Dr Barber has had a career in medical education serving as Chairman of Ophthalmology at The University of Texas in Galveston and St. Francis Medical Center in Pittsburgh. He trained at Washington University in St. Louis, Medical College of Virginia and Massachusetts Eye and Ear Infirmary (Harvard)..He prides himself in being able to explain complicated diseases ant treatments in common understandable language for the average person.AMAZONhttp://johncbarber.com/https://leavittpeakpress.com/http://www.bluefunkbroadcasting.com/root/twia/42326lpp.mp3    

In this episode, Dagny Zhu, MD, speaks with Christina Y. Weng, MD, MBA, FASRS, about women in leadership roles as well as challenges and gender disparities that still exist in health care today. We'd love to hear from you! Send your comments/questions to podcast@healio.com. Follow us on Twitter @Healio_OSN. Mend the Gap would also like to give you the chance to nominate yourself or a colleague for a travel grant! To enter, simply email us at podcast@healio.com! ·        Welcome to this episode 0:11 ·        Introducing Christina Y. Weng, MD, MBA, FASRS 0:22 ·        Tell us about your tenure with Women in Ophthalmology (WIO) 2:20 ·        WIO has seen so much growth. How many members does WIO have? 3:48 ·        Reaching parity in ophthalmology 7:20 ·        Existing gender disparities 8:26 ·        Gender disparity literature 12:48 ·        How did you find mentors, and what challenges did you face in surgical retina? 14:33 ·        How do you think training programs have changed for women? 20:07 ·        How do you balance your life outside of work? 26:28 ·        What advice would you give to others who want to follow your path? 29:00 ·        Thank you! 32:00 Dagny Zhu, MD, is a cornea, cataract and refractive surgeon and medical director and partner at NVISION Eye Centers in Rowland Heights, California. She can be reached on X @DZEyeMD. Christina Y. Weng, MD, MBA, FASRS, is an ophthalmologist and tenured professor at Baylor College of Medicine in Houston.

 First and always: Ask your eye doctor before trying anything—even when Ophthalmology research has proven these benefits.I want to save you time. Below are the four best, research-backed formulas for healing and supporting your eyes using seeds.The Golden Rule: Grind and SoakIn every case, you must grind and soak the seeds in liquid. Otherwise, your gut cannot absorb the nutrients—and in some cases, it can even be dangerous.I personally blend tomatoes, cucumber, and pepper, then add freshly ground seeds and let them soak for 5–10 minutes. Alternatively, I add the ground seeds to my smoothie and blend them.Important warning: Some seeds, like chia and flax, absorb 4–5 times their volume in liquid. They expand into a large mass.How to kill a horse?If you give a horse oats first and then water, the grain swells so rapidly in the gut that it can rupture. The safe way is to let the horse drink water first, then eat the grain.The same principle applies to humans.Never eat dry grains (like chia or flax seeds) and then drink water. Always soak them first.1. Hemp Seeds for the EyesDosage: 30 grams (about 3 tablespoons)Preparation: Grind fresh, soak for at least 5 minutes, then eat.Best time: Every morning for maximum benefit.Research Results:32% reduction in ocular inflammation after 6 weeksHelped with dry eyes and sharper morning vision within 10 daysCalms irritation2. Chia Seeds with Coconut OilDosage: 30 grams chia seeds + 120 ml liquid + 1 teaspoon coconut or olive oilPreparation: Grind chia seeds fresh, soak in liquid, add oil, then eat.Best time: Every morning.Research Results:38% improvement in tear film stability in just 3 weeksLess dry eyes, less burning, less of that "scratchy" feelingEye lubrication improves within 1–2 daysCataract prevention and repair: approximately 90 days3. Ground Flaxseed with Avocado or a Fat SourceDosage: 30 grams flaxseed + 120 ml liquid + ¼ avocado (or 1 teaspoon coconut oil)Preparation: Grind flaxseed fresh, soak in liquid, blend with avocado or oil.Best time: Every morning.Research Results:44% improvement in tear production41% reduction in oxidative stress markers in the lensWithin 1 week: noticeably less drynessWithin 3 weeks: visible improvement in nighttime clarity and reduced glare sensitivity4. Sunflower Seeds with Avocado and Lemon JuiceDosage: 36 grams raw, unsalted sunflower seeds + ¼ ripe avocado + juice of ½ lemonPreparation: Grind sunflower seeds fresh, add liquid, add avocado and lemon juice, then eat.Best time: Every morning.Research Results (for people over 55, studied over 18 months):25% reduced risk of cataract progression34% improvement in lens clarity measurements41% reduction in oxidative damage markersMeasurable slowdown in age-related macular degenerationReduced eye fatigue within hoursMorning blurriness starts clearing within daysAfter 90 days of consistent use: structural eye repairSuggested Rotation PlanTo get a wide range of nutrients, rotate these four formulas:Morning 1: Hemp seedsMorning 2: Chia seeds with coconut oilMorning 3: Ground flaxseed with avocadoMorning 4: Sunflower seeds with avocado and lemon juiceThen repeat.Final ReminderAlways consult your eye doctor before starting any new health regimen—even natural ones. These seeds are powerful medicine for your eyes, and your doctor can help you use them safely and effectively.My Video:  How to Repair Your Eyes with Seeds?  https://youtu.be/A-TKWJQLwFUMy Audio: https://divinesuccess.net/wp-content/uploads/2021/Podcast5/How-to-Repair-Your-Eyes-with-Seeds.mp3

In this SRNA "Ask the Expert" episode moderated by Krissy Dilger, Dr. John Chen of the Mayo Clinic answered audience questions about MOG antibody disease (MOGAD). He discussed diagnosis and the importance of titers and live cell-based assays given possible false positives [00:02:42]. Dr. Chen reviewed acute management with early high-dose steroids, prolonged tapers, and escalation to plasma exchange for severe or steroid-refractory attacks, as well as evolving long-term options including IVIG/subcutaneous IG and IL-6 blockade [00:04:14]. Audience questions covered relapse prediction, vision recovery timelines, fatigue, pregnancy, heredity, symptom interpretation, and whether to stop immunotherapy when antibodies become undetectable [00:12:13]. Finally, Dr. Chen described current and upcoming research, including a trial that is currently enrolling participants, and future prospects for optic nerve regeneration while cautioning against unproven stem cell clinics [00:41:37].John J. Chen, MD, PhD attended the University of Virginia for his undergraduate and combined MD/PhD degrees and completed his Ophthalmology residency and Neuro-Ophthalmology fellowship training at the University of Iowa. He then took a position at the Mayo Clinic in 2014 where he specializes in Neuro-Ophthalmology. Currently, he serves as a Consultant and Professor of Ophthalmology and Neurology, and Neuro-Ophthalmology Fellowship Director at the Mayo Clinic. Among Dr. Chen's awards and honors are the AAO Senior Achievement Award, Top Doctors in Minnesota, the Heed Fellowship, Real World Ophthalmology Inspiring Academic Leader Award, Ophthalmology Teacher of the Year Award four times leading to induction to the Educators Hall of Fame, and the Mayo Clinic Distinguished Educator Award – awarded to the top educator at Mayo Clinic in Rochester. He is an Associate Editor for Ophthalmology and the Journal of Neuro-Ophthalmology, has authored more than 250 peer-reviewed publications, and focuses his research on ophthalmic imaging, idiopathic intracranial hypertension, and optic neuritis, particularly NMOSD and MOG antibody–associated disease.00:00 Welcome and Introductions01:08 What Is MOGAD?02:42 Causes and Triggers03:23 How MOGAD Is Diagnosed04:14 Acute Attack Treatments06:35 Steroid Side Effects08:13 Testing During Treatment09:09 Long Term Therapies12:13 Interpreting MOG Positivity16:51 Eye Symptoms and Vision Fluctuations20:12 Antibody Titers and Severity21:19 Relapse Risk After First Attack23:09 Seizures and Encephalitis24:17 Vision Recovery After Optic Neuritis25:13 Acute Treatment Window25:57 Hereditary Risk Questions26:35 Stopping Azathioprine Safely29:56 Managing Post Attack Pain30:16 Steroids IVIG and Plasma Exchange32:08 Infections as Triggers33:01 Retesting MOG Antibodies35:01 Fatigue and Workup36:23 Prognosis and Life Expectancy37:45 Tinnitus and Brain Pressure39:05 Pediatric and Pregnancy Concerns41:37 Trials and Future Regeneration46:05 Research Resources and Wrap Up

CME credits: 1.00 Valid until: 10-04-2027 Claim your CME credit at https://reachmd.com/programs/cme/enhancing-collaborative-care-in-retinal-diseases-a-focus-on-injection-therapies/37715/ This rebroadcast of a live regional meeting series, part of The Focused Sight Initiative: Quality Improvement Interventions in Retinal Diseases, brings together retina specialists and eye care professionals to address systemic gaps in the timely diagnosis, referral, and management of patients with retinal diseases, including age-related macular degeneration (AMD), diabetic retinopathy (DR), and retinal vein occlusion (RVO). Faculty discuss the clinical consequences of treatment delays, highlight real-world challenges to intravitreal anti-VEGF therapy adherence, and examine disparities in access to care. Learners will explore best practices for identifying patients at risk for progression, optimizing referrals from optometry to retina specialists, and implementing patient-centered communication strategies to improve outcomes. Emphasis is placed on leveraging imaging tools for earlier detection, addressing cultural and socioeconomic barriers, and adopting practice-level interventions to reduce loss to follow-up.=

  This episode of WarDocs features Air Force Lieutenant Colonel, Dr. Charisma Evangelista, the Air Force's leading voice on refractive surgery and an expert in ocular trauma. The conversation begins with her upbringing in the Philippines and her unique path to military medicine, driven by a desire for service and the supportive, collaborative culture she found at the Uniformed Services University. Dr. Evangelista explains her transition from a prospective general surgeon to an ophthalmologist, highlighting the precision of microscopic surgery and the profound impact of sight restoration. She provides a detailed look at the "shield and ship" protocol for managing ruptured globes in combat environments, emphasizing the critical importance of preventing further injury at the point of care.    Dr. Evangelista also shares her experiences as the sole ophthalmologist deployed to Bagram, Afghanistan, where she managed severe, multi-system trauma cases while navigating limited resources. A pivotal moment in the interview occurs when she describes her own experience as a patient; she suffered a retinal detachment while performing surgery, an event that deepened her empathy for those facing vision loss and shaped her leadership style. Currently serving as the Refractive Surgery Consultant to the Air Force Surgeon General, she discusses the technological advancements in corneal collagen cross-linking and refractive standards that maintain pilot and warfighter readiness.    The episode concludes with her leadership philosophy of trust, empathy, and perseverance, alongside her advice for the next generation of military physicians. This comprehensive discussion highlights the technical expertise, emotional resilience, and deep compassion required to protect the vision of the American warfighter, offering listeners an inspiring look at the intersection of high-stakes surgery and humanitarian service. Chapters   (00:00-01:11) Introduction of Lt Col Charisma Evangelista, MD (01:12-05:13) Foundations in Medicine and the Choice of Ophthalmology (05:14-09:32) Specialized Training and Combat Deployment to Afghanistan (09:33-17:00) Ocular Trauma Protocols and Innovations in Refractive Surgery (17:01-22:35) Personal Resilience as a Patient and Leadership Philosophy (22:36-27:10) Advice for Future Medics and Defining a Military Hero Chapter Summaries   (00:00-01:11) Introduction of Lt Col Charisma Evangelista, MD: The episode opens with a tribute to the delicate nature of eye surgery in combat. Host Dr. Doug Soderdahl introduces Dr. Charisma Evangelista as a deeply compassionate healer and a leading expert in military ophthalmology and refractive surgery standards. (01:12-05:13) Foundations in Medicine and the Choice of Ophthalmology: Dr. Evangelista shares her journey from a small town in the Philippines to the Uniformed Services University, highlighting the family-oriented culture of military medical training. She discusses her transition from general surgery to ophthalmology, sparked by a love for microscopic precision and the collaborative nature of the specialty. (05:14-09:32) Specialized Training and Combat Deployment to Afghanistan: The discussion follows Dr. Evangelista through her prestigious civilian fellowship and her subsequent deployment to Bagram Airfield. She details the challenges of serving as the sole ophthalmologist in a combat theater, managing severe ocular trauma and multi-system injuries with limited resources. (09:33-17:00) Ocular Trauma Protocols and Innovations in Refractive Surgery: This section focuses on the "shield and ship" protocol for point-of-injury care and the rewarding outcomes of sight-restoring surgeries. Dr. Evangelista also explains her role as a consultant for the Air Force Surgeon General, detailing how advancements like corneal collagen cross-linking keep service members mission-ready. (17:01-22:35) Personal Resilience as a Patient and Leadership Philosophy: Dr. Evangelista provides a moving account of her own retinal detachment and the traumatic recovery process that followed. She explains how being a patient informed her leadership at the Department of Defense's largest eye center, prioritizing trust, empathy, and perseverance. (22:36-27:10) Advice for Future Medics and Defining a Military Hero: In the final segment, Dr. Evangelista offers encouragement to pre-med and medical students, emphasizing the unique opportunities for growth in military medicine. She reflects on her "Hero of Military Medicine" recognition and her desire to leave a legacy of inspiration and compassionate service. Take Home Messages Protecting the Ruptured Globe: In cases of severe ocular trauma, the most critical step for non-specialists is the "shield and ship" protocol, which involves placing a hard, protective shield over the eye without applying any pressure to the globe. Preventing additional injury at the point of care is essential for giving specialists the best chance to restore a service member's vision. Refractive Surgery as a Readiness Multiplier: Laser vision correction and specialized treatments for conditions like keratoconus are more than elective procedures; they are essential for warfighter readiness. By reducing dependence on eyeglasses and stabilizing corneal conditions, military ophthalmologists ensure that pilots and ground troops can perform their duties with maximum agility and precision. Empathy through the Patient Experience: True compassion in medicine often stems from understanding the fear and uncertainty of the patient. Experiencing a serious medical crisis personally can transform a surgeon's perspective, allowing them to lead with greater empathy and build deeper trust with those under their care. The Collaborative Power of Military Medicine: The military medical system thrives on a culture that prioritizes collective success over individual competition. This foundation of unit cohesion ensures that physicians work together across specialties to provide the highest standard of care in both domestic hospitals and austere combat environments. Persistence in the Face of Adversity: Success in high-stakes fields like ophthalmology requires the ability to persevere through personal health crises, professional challenges, and the rigors of deployment. Growth and innovation often occur as a direct result of these struggles, making a leader more resilient and effective in their mission to serve.   Episode Keywords Military Medicine, Ophthalmology, Ocular Trauma, Eye Surgery, Refractive Surgery Standards, LASIK, PRK, K-LEX, Corneal Collagen Cross-linking, Keratoconus, Bagram Airfield, Combat Medic Training, Eye Injury Protocols, Shield and Ship, Retinal Detachment, Uniformed Services University, Air Force Surgeon General, Hero of Military Medicine, Surgical Leadership, Medical Humanitarian Missions, WarDocs Podcast, Dr. Charisma Evangelista, Sight Restoration, Combat Surgery, Military Healthcare. Hashtags #MilitaryMedicine, #Ophthalmology, #CombatSurgery, #EyeHealth, #WarDocs, #AirForceMedicine, #RefractiveSurgery, #VeteransHealth   Honoring the Legacy and Preserving the History of Military Medicine The WarDocs Mission is to honor the legacy, preserve the oral history, and showcase career opportunities, unique expeditionary experiences, and achievements of Military Medicine. We foster patriotism and pride in Who we are, What we do, and, most importantly, How we serve Our Patients, the DoD, and Our Nation.   Find out more and join Team WarDocs at https://www.wardocspodcast.com/ Check our list of previous guest episodes at https://www.wardocspodcast.com/our-guests Subscribe and Like our Videos on our YouTube Channel: https://www.youtube.com/@wardocspodcast Listen to the “What We Are For” Episode 47. https://bit.ly/3r87Afm   WarDocs- The Military Medicine Podcast is a Non-Profit, Tax-exempt-501(c)(3) Veteran Run Organization run by volunteers. All donations are tax-deductible and go to honoring and preserving the history, experiences, successes, and lessons learned in Military Medicine. A tax receipt will be sent to you. WARDOCS documents the experiences, contributions, and innovations of all military medicine Services, ranks, and Corps who are affectionately called "Docs" as a sign of respect, trust, and confidence on and off the battlefield,demonstrating dedication to the medical care of fellow comrades in arms.     Follow Us on Social Media Twitter: @wardocspodcast Facebook: WarDocs Podcast Instagram: @wardocspodcast LinkedIn: WarDocs-The Military Medicine Podcast YouTube Channel: https://www.youtube.com/@wardocspodcast

In our latest episode with the discuss the promising results of a Phase I clinical trial looking at kamuvidine 8 an inflammasome inhibitor in the treatment of geographic atrophy with Dr. Jayakrishna Ambati, Guerry Professor of Ophthalmology at the University of Virginia School of Medicine.

In this episode of Eyeluminaries, John A. Hovanesian, MD, FACS, and Jim Mazzo are live from Hawaiian Eye 2026, with guests Baruch D. Kuppermann, MD, PhD and L. Jay Katz, MD. They discuss everything from their unique career journeys to the current treatments and procedures in eye care. Welcome to Eyeluminaries 00:10 Recap of AAO episode 00:34 Intro of Baruch D. Kuppermann, MD, PhD 01:28 What made you enter retina and how has your career evolved? 03:02 The Gavin Herbert Eye Institute 06:02 What are your other interests? 12:09 Nonprofit work and the Armenian EyeCare Project 13:07 Intro of L. Jay Katz, MD 17:14 How did you get into glaucoma? 18:03 How are things going to evolve in treatment and procedures? 20:28 What was the driving force behind leaving academia and working with Glaukos? 25:01 Tell us a favorite Tom Burns story! 26:44 Thank you! 29:50 Baruch D. Kuppermann, MD, PhD, is the Roger F. Steinert Professor, Chair of the Department of Ophthalmology, and Director of the Gavin Herbert Eye Institute at the University of California, Irvine. L. Jay Katz, MD, is the chief medical officer at Glaukos. We'd love to hear from you! Send your comments/questions to eyeluminaries@healio.com. Follow John Hovanesian on X @DrHovanesian.

The use of intracameral antibiotics - specifically intracameral moxifloxacin - has become relatively mainstream practice in cataract surgery. But how effective is it in preventing endophthalmitis? Are ophthalmologists administering it correctly?  And what are some of the potential adverse effects that can result from intracameral moxifloxacin? Leading expert in the field, Dr. Steve Arshinoff, joins the podcast. This episode is sponsored by Thea Pharma Canada - https://www.theapharma.caBecome a supporter of this podcast: https://www.spreaker.com/podcast/blind-spot-the-eye-doctor-s-podcast--5819306/support.

In the past few days, Andrew Huberman has been making waves with a fresh Huberman Lab podcast episode that dropped on how hormones shape sexual orientation and behavior, featuring neuroscientist Dr. Marc Breedlove from Michigan State University. According to the Huberman Lab website, they dove deep into prenatal testosterone's role in romantic attractions, brain development, and male-female differences, sparking buzz among fans tracking his neuroscience breakdowns. The full episode hit YouTube too, racking up views as listeners geek out on the science of what wires us romantically.Meanwhile, Huberman's Instagram at hubermanlab lit up with reels from his Stanford perch as Professor of Neurobiology and Ophthalmology, pushing neuroscience education and podcast plugs—his bio there touts the Huberman Lab as a go-to for research-backed health hacks. No major personal drama or unconfirmed gossip swirling, but whispers in comment sections speculate on his next big collab, though that's pure fan chatter without verification.A standout recent clip from his chat with Dr. Richard Davidson, circulating on YouTube, tackles digital overload's toll on mental health—think stimulus-captured attention from apps eroding youth psyches, echoing the 2023 Surgeon General's advisory on social media's linear link to teen psychiatric woes. Huberman warns adults are hitting that "black ice" of internet addiction too, positioning him as the voice guiding us through tech's dark side. This ties into his ongoing push for "digital hygiene" skills, a theme with real biographical heft as he cements his role as science's wellness whisperer.No public appearances or business deals popped in the last 72 hours from reliable outlets, keeping the focus on his content machine churning out brain-boosting gold. In the past 24 hours, no blockbuster headlines, but that hormone episode is trending steady.Thanks for listening—subscribe to never miss an update on Andrew Huberman and search the term Biography Flash for more great biographies. This has been a Quiet Please production.This content was created in partnership and with the help of Artificial Intelligence AI

The post Do the Eyes Have It? Corticosteroid Use and Stewardship in Ophthalmology appeared first on JDDonline - Journal of Drugs in Dermatology.

The post Do the Eyes Have It? Corticosteroid Use and Stewardship in Ophthalmology appeared first on JDDonline - Journal of Drugs in Dermatology.

Today, I'm putting on my "career counselor" hat to address the latest medical social media drama: a spine surgeon who decided to take a break from clinical practice just six months in to become a full-time content creator. While the internet is full of opinions, I'm sharing why I choose to stay in the game, even when YouTube decides to reclassify my skits and slash my ad revenue. For all you med students and residents watching, I'm breaking down why medicine is the ultimate "safety net" that gives you the freedom to create without the pressure of the algorithm. After the break, we're starting a new series called "Thing I Love, Thing I Hate." I'll tell you why a simple stool in the OR convinced me to become an ophthalmologist and why cataract surgery remains the most rewarding 10 minutes of my day. Then, we'll dive into the "Thing I Hate": Neurotrophic Keratitis. It's a degenerative disease where your eye loses the ability to feel pain, which sounds like a superpower, but is actually a dangerous nightmare that can lead to permanent damage. Takeaways: The Illusion of Digital Freedom: Why relying on "owning" an audience on TikTok or YouTube is a risky bet compared to the stability of a medical degree. The "Sitting Down" Advantage: How a single stool during a med school rotation can change the entire course of your career. The 50+ LASIK Trap: Why you should be wary of "LASIK mills" and why cataract technology can actually do more for older patients than laser surgery. The Danger of Comfortable Eyes: Why a lack of pain during a corneal infection is actually a red flag for a "sensitive" organ like the eye. Cutting-Edge Nerve Repairs: How surgeons are experimenting with transplanting leg nerves into the eye to restore vision and feeling. To Get Tickets to Wife & Death: You can visit Glaucomflecken.com/live  We want to hear YOUR stories (and medical puns)! Shoot us an email and say hi! knockknockhi@human-content.com Can't get enough of us? Shucks. You can support the show on Patreon for early episode access, exclusive bonus shows, livestream hangouts, and much more! –⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ http://www.patreon.com/glaucomflecken⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠  Also, be sure to check out the newsletter: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://glaucomflecken.com/glauc-to-me/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ If you are interested in buying a book from one of our guests, check them all out here: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.amazon.com/shop/dr.glaucomflecken⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ If you want more information on models I use: Anatomy Warehouse provides for the best, crafting custom anatomical products, medical simulation kits and presentation models that create a lasting educational impact.  For more information go to Anatomy Warehouse DOT com. Link: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://anatomywarehouse.com/?aff=14⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Plus for 15% off use code: Glaucomflecken15 -- A friendly reminder from the G's and Tarsus: If you want to learn more about Demodex Blepharitis, making an appointment with your eye doctor for an eyelid exam can help you know for sure. Visit ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠http://www.EyelidCheck.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ for more information.  Produced by⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Human Content⁠ Learn more about your ad choices. Visit megaphone.fm/adchoices

In this episode, Jason M. Raidbard, Executive Administrator of Ophthalmology and Visual Sciences at UChicago Medicine, discusses the impact of upcoming Medicaid policy changes, evolving payer dynamics, and the growing role of AI in care coordination. He also shares leadership advice on mentorship, authenticity, and building meaningful relationships to drive long term success.

Dr. Rajesh Rao interviews Dr. Bradley T. Smith on his study to report the rate and rationale for vitrectomy after retinal detachment repair with pneumatic retinopexy, from his Ophthalmology Retina article, "Rate and Rationale for Vitrectomy after Pneumatic Retinopexy." Rate and Rationale for Vitrectomy after Pneumatic Retinopexy. Smith, Bradley T. et al. Ophthalmology Retina, Volume 9, Issue 11, 1053 – 1061. Looking for ways to give back? By becoming an EyeCare America volunteer, you could help provide eye care to those in your community most in need, from the comfort of your own office. EyeCare America, established by the American Academy of Ophthalmology in 1985 as the first public service program for eye care, connects uninsured and underinsured patients 18 and over in need of medical eye exams with local ophthalmologists. Visit eyecareamerica.org for more info.

In this episode, we will learn from Alicia Reiser, OTD, MS OTR/L, ADHD-RSP. With over 24 years of experience as an occupational therapist, Dr. Reiser is passionate about redefining rehabilitation through a truly integrative and evidence-based lens. After earning her clinical doctorate from Salus University at Drexel in 2018, specializing in vision remediation, Alicia opened her private practice, A Rise Above Occupational Therapy Services, the same year. Her practice was born from a mission to bridge the gap for individuals recovering from concussions, as well as those with ADHD who were often underserved, aged out of traditional services, or never realized how transformative occupational therapy could be. At A Rise Above, Alicia combines neurological rehabilitation with vision remediation, cognitive retraining, trauma-informed care, interoceptive awareness, and polyvagal interventions to address autonomic nervous system dysregulation. Her holistic, brain-based approach helps clients regain not just function—but balance, confidence, and control in daily life. Dr. Reiser's work reflects her commitment to helping people truly rise above their challenges through science, compassion, and innovation in occupational therapy.Contact & Resources:Website: www.ariseaboveoccupationaltherapyservies.comBook and consulting website link: https://neurotconsulting.com/Business website: https://www.ariseaboveoccupationaltherapyservices.com/Blog: https://www.ariseaboveoccupationaltherapyservices.com/post/top-3-reasons-why-occupational-therapy-and-optometry-should-be-best-friendsYouTube channel: https://www.youtube.com/channel/UCjYkggEWqhKMVwWuX-jaoeQFacebook: https://www.facebook.com/ARiseAboveOT/Facebook: https://www.facebook.com/p/Neurot-Consulting-61556820418616/IG: https://www.instagram.com/ariseaboveot/IG: https://www.instagram.com/neurot.consulting/Drexel OTD program: https://drexel.edu/academics/grad-professional-programs/cnhp/occupational-therapy-post-professionalresources/articles: https://scholarworks.wmich.edu/ojot/vol8/iss4/6/https://scholarworks.wmich.edu/ojot/vol11/iss3/8/https://cdn.ymaws.com/www.covd.org/resource/resmgr/vdr/vdr_6_3/vdr6-3_article_fessier_web.pdfhttps://scholarworks.wmich.edu/ojot/vol12/iss4/2/Book: https://www.routledge.com/Understanding-and-Managing-Vision-Deficits-A-Guide-for-Occupational-Therapists/Scheiman/p/book/9781032882871AOTA Community of Practice: Occupation Based Neuro Remedial Vision Rehab: https://www.aota.org/community/communities-of-practiceNORA: https://noravisionrehab.org/Screening tool: Convergence Insufficiency Symptom Survey (CISS): https://pmc.ncbi.nlm.nih.gov/articles/PMC2782898/figure/F2/Screening tool: QOL Symptom Survey: https://www.oepf.org/wp-content/uploads/2021/06/JBO-18-2-Harris.pdfAs always, I welcome any feedback & ideas from all of you, or if you are interested in being a guest on future episodes, please do not hesitate to contact Patricia Motus at transitionsot@gmail.com or DM via Instagram @transitionsotTHANK YOU for LISTENING, FOLLOWING, DOWNLOADING, RATING, REVIEWING & SHARING “The Uncommon OT Series” Podcast with all your OTP friends and colleagues!Full Episodes and Q & A only available at:https://www.wholistic-transitions.com/the-uncommon-ot-seriesSign Up NOW for the Transitions OT Email List to Receive the FREEUpdated List of Uncommon OT Practice Settingshttps://www.wholistic-transitions.com/transitionsotTo Add Your Profile to The Uncommon OT Directory:https://www.wholistic-transitions.com/requestFor Non-Traditional OT Practice Mentorship w/ Patricia:https://docs.google.com/forms/d/e/1FAIpQLSeC3vI5OnK3mLrCXACEex-5ReO8uUVPo1EUXIi8FKO-FCfoEg/viewformHappy Listening Friends! Big OT Love!All views are mine and guests own.

We're joined by Dr. David Perlmutter of Perlmutter Eye Center. Ray Graf hosts.

When a posterior capsule rupture occurs during cataract surgery, the standard teaching is that we do an anterior vitrectomy if the hyaloid face is broken and vitreous comes forward. But why is the anterior vitrectomy so important? Is it always 100% necessary? And what are some tips on performing the anterior vitrectomy as safely and effectively as possible. Dr. Uday Devgan, aka The Cataract Coach, joins the podcast. Check out The Cataract Coach at https://www.youtube.com/@UdayDevganThis episode is sponsored by Thea Pharma Canada - https://www.theapharma.ca/Become a supporter of this podcast: https://www.spreaker.com/podcast/blind-spot-the-eye-doctor-s-podcast--5819306/support.

Today, we are joined by Dr. Jane Bailey, who is a comprehensive and neuro-ophthalmologist who made the bold decision mid-career to return to fellowship training. Tune in to hear Dr. Bailey's journey of reinvention, service, and leadership in ophthalmology.  Subscribe to the podcast:  https://MayoClinicOphthalmology.podbean.com   Follow and reach out to us on X and IG: @mayocliniceye

We're kicking off season seven with an in-depth look at the wild world of ophthalmology, where scientists are pushing the boundaries of what's possible for vision treatments. In this episode, co-host Danielle Mandikian is joined by guests Deepak Lamba, Director and Distinguished Scientist, Ophthalmology, and Susie Crowell, Senior Director, Project Team Leader, to explore the latest in the field of ophthalmology since our season five episode on eye diseases. Together, they dive into the bizarre biology of how our eyes actually work, unpack how and why eye diseases develop, and discuss how transformative new therapies could one day restore sight. Read the full text transcript at www.gene.com/stories/the-wild-world-of-eyeballs

In our latest update, we discuss strategies for developing a teleretinology network with Dr. Glenn Yiu, Professor of Ophthalmology, University of California, Davis.

One of the most powerful tools for healthy ageing might be something you've barely thought about: light. Most of us spend the majority of our time under LED lighting that's stripped of the very wavelengths our bodies need to function well – and the impact on our metabolism, energy and long-term health is only just being understood.Professor Glen Jeffery, neuroscientist at UCL's Institute of Ophthalmology, joins Liz to explain why a light deficiency could be quietly accelerating ageing, what it means for your mitochondria, and the simple changes – starting with your light bulbs – that could make a real difference to how you feel and age.In this episode:Why infrared light is the most overlooked wavelength for human healthHow LED lighting creates a "light deficiency" – and why Glen calls it modern-day scurvyThe profound effect light has on your mitochondria and energy productionWhy morning light mattersWhat the research really says about red light face masks and infrared saunasHow changing your light environment could help regulate blood sugar and metabolismThe simple practical changes to make at home – and why Glen's first recommendation is to get a dogLinks mentioned in the episode:Anti blue light glassesGet in touch with a question for Liz:Email: podcast@lizearlewellbeing.comWhatsApp: 07518 471 846More from Liz:Preorder Liz's new book – How to AgeA Better Second Half Follow Liz on InstagramFollow Liz Earle Wellbeing on InstagramSome links may be affiliate links, which help support the show at no extra cost to you. Read our Affiliate Policy for more information. Hosted on Acast. See acast.com/privacy for more information.

Amol Sura, MD, Foster Center for Ocular Immunology, Dept of Ophthalmology, Duke University, Durham, North Carolina, discusses the diagnosis and management of plasminogen deficiency, a rare condition in which the eyes are first affected, but it manifests in mucous membranes throughout the body.“The eyes are a window into the health of the entire body,” said Dr. Sura, and that is precisely the case for patients with plasminogen deficiency type 1 (PLGD-1). For this rare, inherited condition, the first symptom observed is the growth of ligneous or wood-like lesions on the surface of the eye or eyelid (in about 80% of patients, first seen at ages 9–10 months). It is often characterized as ligneous conjunctivitis. If left untreated, PLGD-1 may result in severe—even life-threatening—complications, affecting mucous membranes in many other areas of the body, including the respiratory tract, central nervous system, gingiva, and genitourinary tract. Vision loss, tooth loss, and other serious outcomes have been reported. In this homozygous condition involving the PLG gene, the plasminogen protein is defective; it cannot effectively perform its intended function of breaking down fibrin. The result is the formation of fibrin clots appearing as ligneous growths or pseudomembranes. Once removed, these lesions reappear, and this should tip off the physician (most often an ophthalmologist) that something systemic is the cause.The diagnosis of PLGD-1 is straightforward: A blood test showing decreased plasminogen activity levels is confirmatory. A genetic test is not necessary. In the past, management of PLGD-1 was through the use of off-label therapies, including heparin eyedrops, immunologics, and plasma infusions. A form of intravenous human plasminogen was approved by the U.S. Food and Drug Administration in 2021, and this is considered the standard of care today. With this therapy, plasminogen plasma levels can be restored, lowering the risk of new fibrin clots throughout the body. For newly diagnosed patients, the best advice for caregivers is to establish a relationship with a hematologist, who will serve as the principal care provider. Although a multidisciplinary care team is required (e.g., ophthalmology, obstetrics/gynecology, dentistry), the need for other specific providers will depend on the other organs or sites affected. Dr. Sura believes that PLDG-1 is underdiagnosed, but with increasing awareness, and the availability of effective treatment, diagnosis and management of these patients can be improved today.For more information on PLGD-1, visit https://checkrare.com/plasminogen-deficiency-fibrin-accumulation-and-its-effects-on-patients-2/

Send a textAbout Dr. Dr. Cecelia KoettingDr. Koetting is an assistant professor at the University of Colorado School of Medicine in the Department of Ophthalmology in Denver, CO. Her primary focus is on anterior segment and ocular surface disease, neuro-optometry, and perioperative care. She partakes in clinical research and has served as an externship director and adjunct faculty for several schools and colleges of optometry. Dr. Koetting is a member of Intrepid, a fellow in the American Academy of Optometry, a diplomate of the American Board of Optometry, an active member of AOA, and has served as both a local and state officer within AOA. She was named young optometrist of the year by the state of Virginia. Dr. Koetting lectures locally, nationally, and internationally at conferences; continually contributes articles to; and serves on the editorial board for multiple publications.

Dr. Edmund Tsui is joined by Dr. Shu Feng, author of Ophthalmology's Assessing the Efficacy of Ophthalmic Transfers to an Academic Level 1 Trauma Hospital, to discuss her study of ophthalmic transfers to an academic level 1 trauma center and the accuracy of transferring diagnoses and rate of intervention after transfer. Assessing the Efficacy of Ophthalmic Transfers to an Academic Level 1 Trauma Hospital. Hopkin, Blake et al. Ophthalmology, Volume 133, Issue 1, 24 – 30.

Drs. Zubair Ansari and Kat Talcott join to discuss the 2026 ophthalmology residency match, especially focusing on the declining match rate for first time applicants and what that means for future applicants and reapplicants. Listeners, as we approach our 500th episode, we will be having a Q&A session featuring questions and thoughts from you! It's your chance to have your voice heard on the podcast.Please record an audio / video of your question and upload it to the linked form (https://forms.gle/nyv3fvCHZJ4XzQe67). We are excited to hear what you have to say!

In our latest episode, we discuss the results of the PRIMA retinal implant in treating eyes with center involved geographic atrophy as presented in a recent New England Journal of Medicine article. 85% of eyes had meaningful improvement in vision at one year with Dr. Daniel Palanker, Professor of Ophthalmology and Electrical Engineering, Stanford University.

Send a textAbout Dr. Rishi P. Singh MD,Dr. Rishi P. Singh MD is a staff surgeon, vice president, and chief medical officer at theCleveland Clinic Martin Health and Professor of Ophthalmology at the Lerner College of Medicine in Cleveland Ohio. He received his bachelors and medical degrees from Boston University and completed his residency at the Massachusetts Eye and Infirmary Harvard Combined Program in Boston, Massachusetts. Dr. Singh then completed a medical and surgical fellowship at the Cole Eye Institute in Cleveland, Ohio.He specializes in the treatment of medical and surgical retinal disease such as diabeticretinopathy, retinal detachment, and age-related macular degeneration. Dr. Singh hasauthored more than 250 peer reviewed publications, books, and book chapters and serves as the principal investigator of numerous national clinical trials advancing the treatment of retinal disease. Dr. Singh is the former president on the Retina World Congress and is on the board of the American Society of Retina Specialists.Dr. Singh has been honored with several research recognitions such as the Alpha Omega Alpha Research Award and American Society of Retina Specialists Senior Honor Award.

Host Dr. Jay Sridhar welcomes Dr. Sarwar Zahid to unpack a recent American Journal of Ophthalmology perspective essay on the growing segment of hospital-employed ophthalmologists. They examine the appeal of the hospitalist model—shift-based work, reduced administrative burden, and work-life balance—alongside potential drawbacks, including income ceilings, RVU pressure, and burnout. The conversation broadens to declining physician ownership, the challenges of hospital call coverage, and the downstream threat to residency training. The episode finally shifts to whether a focused practice designation (FPD) could help define subspecialty expertise, improve patient care, and give ophthalmologists a stronger seat at the bargaining table. Discussed in this episode: Thomson M, Browning DJ. The Hospital Employed Ophthalmologist: A Growing Segment of the Profession. Am J Ophthalmol. 2026 Jan 18;284:208-215. For all episodes or to claim CME credit for selected episodes, visit www.aao.org/podcasts.

In today's podcast, we visit with Dr. Michael Repka, current president of the American Academy of Ophthalmology. Tune in to hear about AAO leadership efforts including advocacy, from Medicare to medical code values.    Subscribe to the podcast:  https://MayoClinicOphthalmology.podbean.com   Follow and reach out to us on X and IG: @mayocliniceye 

This episode covers squint.Written notes can be found at https://zerotofinals.com/paediatrics/neurology/squint/Questions can be found at https://members.zerotofinals.com/Books can be found at https://zerotofinals.com/books/The audio in the episode was expertly edited by Harry Watchman.

Drs. Louie Cai and Ted Leng join to discuss the state of artificial intelligence in ophthalmology as of February 2026.

In the second episode of this two-part series, Drs. Justin Abbatemarco, Valérie Biousse, and Nancy J. Newman discuss the risk of non-arteritic ischemic optic neuropathy and how to counsel patients around GLP-1 medications.  Show transcript:  Dr. Justin Abbatemarco: Hello and welcome back. This is Justin Abbatemarco again with Valarie Biousse and Nancy Newman talking about non-arteritic ischemic optic neuropathy. I think the other major point that we had a discussion in the podcast was around the GLP-1 medications, which you mentioned have been truly life-changing for diabetes management and obesity. Can we talk about the risk of non-arteritic ischemic optic neuropathy and how you're counseling patients around this class of medications? Dr. Nancy J. Newman:  Absolutely. This is probably one of the most difficult things we are dealing with because it is something that is in process and progress right now. We don't have all the information yet, but it would appear that there is likely a small association of about slightly less than two times risk in patients who are taking these medications of having NAION with a resultant still very, very small overall risk. And it is not necessarily causal. This has prompted the European Medicines Agency to say that these patients should have their GLP-1 RAs stopped if they have NAION. Our own FDA and certainly the American Academy of Ophthalmology and the North American Neuro-Ophthalmology Society have not taken that step, but have suggested that this be shared decision-making, not only with the person who makes this diagnosis of an NAION in the patient, but with their primary care doctor or the provider who has felt that a GLP-1 receptor agonist is important for this patient's treatment and health. Dr. Justin Abbatemarco: More to come. We're going to have you back to have discussions as we learn more and better understand the disease and how we help our patients with both their diagnosis and treatment. Thank you so much for your time. 

Dr. Natalia Vergara is an Assistant Professor of Ophthalmology at the Sue Anschutz-Rodgers Eye Center, University of Colorado School of Medicine on the Anschutz Medical Campus. Natalia uses stem cells to understand how the retina forms during development and how it degenerates during disease with the goal of developing therapies to help patients who suffer from vision loss. For her research, Natalia uses a type of stem cells called induced pluripotent stem cells which can be reprogrammed so they can form any type of cell in the body. With these cells, they can make human retina tissue using any individual's cells in a petri dish in the lab to better understand diseases, test treatments, and potentially prepare retinas for transplant. In her free time, Natalia loves hanging out, cooking, and enjoying food with friends and family, including her husband and two young kids. Natalia is also an avid traveler, and she delights in the thrill of discovery that comes along with exploring new places. Natalia received her B.S. in biochemistry from the National University of the Litoral in Argentina. She worked as an instructor and research intern at the National University of Entre Ríos for about three years before beginning graduate school. Natalia was awarded her PhD in retinal regenerative biology from Miami University in Ohio. Afterwards, she conducted postdoctoral research at the Wilmer Eye Institute of Johns Hopkins School of Medicine. She served as a Research Associate Faculty member at Johns Hopkins School of Medicine for about two years before joining the faculty at the University of Colorado. Natalia has received awards for research and for mentoring, including the Ruben Adler Research Award from the Wilmer Eye Institute at Johns Hopkins University School of Medicine in 2012, and she was selected as an Emerging Vision Scientist to participate in the Third Annual EVS day on Capitol Hill by the National Alliance for Eye and Vision Research in 2017. In our interview, Natalia tells us more about her life and science.

Want to Start or Grow a Successful Business? Schedule a FREE 13-Point Assessment with Clay Clark Today At: www.ThrivetimeShow.com   Join Clay Clark's Thrivetime Show Business Workshop!!! Learn Branding, Marketing, SEO, Sales, Workflow Design, Accounting & More. **Request Tickets & See Testimonials At: www.ThrivetimeShow.com  **Request Tickets Via Text At (918) 851-0102   See the Thousands of Success Stories and Millionaires That Clay Clark Has Helped to Produce HERE: https://www.thrivetimeshow.com/testimonials/ Download A Millionaire's Guide to Become Sustainably Rich: A Step-by-Step Guide to Become a Successful Money-Generating and Time-Freedom Creating Business HERE: www.ThrivetimeShow.com/Millionaire   See Thousands of Case Studies Today HERE: www.thrivetimeshow.com/does-it-work/